We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-3.5%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$128B
AUM Growth
-$140B
Cap. Flow
-$131B
Cap. Flow %
-102.41%
Top 10 Hldgs %
21.91%
Holding
5,876
New
1,592
Increased
605
Reduced
2,310
Closed
907

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.85B
2
MSFT icon
Microsoft
MSFT
+$1.75B
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.22B
4
AMZN icon
Amazon
AMZN
+$1.04B
5
IYR icon
iShares US Real Estate ETF
IYR
+$924M

Sector Composition

Rank Sector Weight
1 Technology 22.06%
2 Financials 14.44%
3 Healthcare 10.25%
4 Consumer Discretionary 9.7%
5 Communication Services 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVFM
4401
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$12K ﹤0.01%
2,433
AIP icon
4402
Arteris
AIP
$1.35B
$11K ﹤0.01%
+855
New +$12.8K
CVRX icon
4403
CVRx
CVRX
$143M
$11K ﹤0.01%
+1,802
New +$14.5K
FBT icon
4404
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.87B
$11K ﹤0.01%
72
GRN icon
4405
iPath Series B Carbon Exchange-Traded Notes
GRN
$23.8M
$11K ﹤0.01%
+371
New +$12.1K
IPHA
4406
Innate Pharma
IPHA
$164M
$11K ﹤0.01%
+3,411
New +$12.6K
PLSE icon
4407
Pulse Biosciences
PLSE
$2.43B
$11K ﹤0.01%
2,259
-14,629
-87% -$120K
PRTH icon
4408
Priority Technology Holdings
PRTH
$544M
$11K ﹤0.01%
1,833
-10,520
-85% -$61K
SMMT icon
4409
Summit Therapeutics
SMMT
$10.7B
$11K ﹤0.01%
+4,361
New +$11K
SPYM
4410
State Street SPDR Portfolio S&P 500 ETF
SPYM
$160B
$11K ﹤0.01%
+200
New +$10.5K
VALU icon
4411
Value Line
VALU
$323M
$11K ﹤0.01%
160
-1,029
-87% -$60.5K
VLRS
4412
Controladora Vuela Compania de Aviacion
VLRS
$914M
$11K ﹤0.01%
+591
New +$10.5K
SYRS
4413
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$11K ﹤0.01%
935
-6,053
-87% -$108K
RWGV
4414
DELISTED
Direxion Russell 1000 Growth Over Value ETF
RWGV
$11K ﹤0.01%
+100
New +$11.3K
RVACW
4415
DELISTED
Riverview Acquisition Corp. Warrant
RVACW
$11K ﹤0.01%
+23,051
New +$10.5K
REV
4416
DELISTED
Revlon, Inc.
REV
$11K ﹤0.01%
1,244
-7,449
-86% -$71.2K
APT icon
4417
Alpha Pro Tech
APT
$50.7M
$10K ﹤0.01%
2,465
BIP icon
4418
Brookfield Infrastructure Partners
BIP
$19.5B
$10K ﹤0.01%
242
-751
-76% -$30.3K
CDIOW icon
4419
Cardio Diagnostics Holdings Inc Warrant
CDIOW
$730K
$10K ﹤0.01%
+49,100
New +$11.7K
DAVA icon
4420
Endava
DAVA
$153M
$10K ﹤0.01%
77
FCAP icon
4421
First Capital
FCAP
$211M
$10K ﹤0.01%
263
HOFV
4422
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$10K ﹤0.01%
+411
New +$10.6K
NL icon
4423
NLI Holdings
NL
$290M
$10K ﹤0.01%
1,361
-8,799
-87% -$59.2K
OWL icon
4424
Blue Owl Capital
OWL
$6.87B
$10K ﹤0.01%
+758
New +$9.6K
STN icon
4425
Stantec
STN
$7.92B
$10K ﹤0.01%
200

Similar funds

Barclays's Q1 2022 Portfolio in Review

As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Barclays opened a new position in Stellantis worth $331M.

  • Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
  • Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
  • Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
  • Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
  • Barclays opened 1,592 new positions and closed 907 in Q1 2022.
  • Barclays's portfolio value fell 52% quarter-over-quarter to $128B.

Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.